Verdict: Better than nothing, but youre hoping your body does the work
[1] NICE guidance (NG28) recommends GLP-1 receptor agonists like semaglutide for adults with type 2 diabetes when: Triple therapy with metformin and two other oral drugs is ineffective, not tolerated, or contraindicated The person has a BMI of 35 kg/m or higher (adjusted for ethnicity) and specific psychological or medical problems associated with obesity BMI is lower than 35 kg/m but insulin therapy would have significant occupational implications or weight loss would benefit other obesity-related comorbidities Ozempic is available in pre-filled, multi-dose pens delivering 0.25 mg, 0.5 mg, 1 mg, or 2 mg doses
The Gene Ontology knowledgebase in 2023
Studies have shown that sitagliptin is a selective and potent inhibitor (greater than 80%) of the DPP-4 enzyme
Our care team can walk you through the menu and confirm coverage before you book
The proportion of lean mass loss to total weight loss was similar to other obesity treatments, indicating retatrutide maintains muscle mass while promoting fat reduction [6]
